Report Categories
View AllRecent Articles
View All
What Vanda Pharmaceuticals VNDA does that builds long term value Q4 2025 Better Than Expected
The real story behind Presidio SQFTW earnings numbers SQFTW QX Earnings Presidio Reports No Disclosed Financial Data This Quarter
What base case VOC Energy VOC Risk Aversion 20260501
Why McKinley MKLY earnings could be a turning point
CPF LIFE vs SelfInvesting The Critical Factor of Financial Management in Retirement
Global Infrastructure Funding Doubles in Five Years Japanese Banks at Forefront
Feds Williams Signals Current Rate Policy Appropriate Amid Economic Outlook
Petroleum Products Export Share Drops to 88 in FY26 Lowest in a Decade
SpaceX IPO Could Surpass Historic Debuts A Look at the Biggest Stock Market Entries
AnheuserBusch InBev Shares Slip as Quarterly Sales Miss Market Expectations
KN Q1 2026 Earnings EPS Surpasses Estimates Stock Rises Over 4
Coeur Mining CDE Q1 2026 Earnings EPS Misses Street Estimates as Costs Pressure Bottom Line
Atlanticus Holdings ATLCP Q1 2026 Earnings Preferred Stock Reports Strong EPS Beat Stock Rises
CNO Financial Group Q1 2026 Earnings Strong Earnings Beat Fails to Lift Shares
HSTM Q1 2026 Earnings EPS Surpasses Estimates by Over 21
Affiliated Managers Group Inc AMG Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher
Regentis Biomaterials RGNT Slides 97 as Stock Tests Support Near 185
Western Asset Emerging Markets Debt Fund EMD Edges Higher as Yield Appeal Persists
STAAR Surgical Faces Modest Decline as Shares Test Key Support Levels
Indigo Acquisition Corp INAC Shows Mild Uptick as Shares Hover Near Support Levels
Fresh Del Monte Produce FDP Gains 14 as Shares Approach Key Resistance Level
OPTU Q1 2026 Earnings Massive EPS Miss Sends Shares Lower
Alta Equipment Group Inc ALTG Q1 2026 Earnings EPS Miss Widens as Losses Deepen
Armata Pharmaceuticals ARMP Q1 2026 Earnings Massive EPS Miss as PreRevenue Biotech Struggles with Costs
Jiayin Group Q4 2024 Earnings EPS Delivers Solid Profitability Stock Gains Over 6
OXLC Q4 2025 Earnings EPS Misses Estimates as Net Investment Income Falls Short
GLUE Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline